Emerging data suggest Retatrutide , a dual activator targeting both the gut-brain axis and GIP , appears to represent a significant step forward for weight loss . Initial clinical investigations have https://getretatrutideaustralia.com/blog/retatrutide-vs-tirzepatide-semaglutide